Skip to main content
SpringerLink
Log in

Vasculitis in the Central Nervous System

  • Chapter
  • First Online:
The Immunology of Cardiovascular Homeostasis and Pathology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1003))

Abstract

Central nervous system (CNS) vasculitides are a heterogeneous group of disorders characterized by an inflammatory cell infiltration and necrosis of blood vessel walls in the brain, spinal cord, and the meninges. The CNS complications are likely to be fatal without judicious use of immunosuppression; thus, early diagnosis may prevent from damage and disability. This chapter updates our knowledge on CNS vasculitis-related immunological mechanisms, neurological complications, diagnosis, and management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Riggs JE. Neurological consequences of systemic disease. In: Bradley W, Daroff R, Fenichel G, Marsden D, editors. Neurology in clinical practice. Boston: Butterworth-Heinemann; 1991. p. 841–60.

    Google Scholar 

  2. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.

    Article  CAS  PubMed  Google Scholar 

  3. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–71.

    Article  PubMed  Google Scholar 

  4. Weyand C, Joyce Liao Y, Goronzy JJ. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol. 2012;32(3):259–65.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nesher G. Neurologic manifestations of giant cell arteritis. Clin Exp Rheumatol. 2000;4(Suppl 20):S24–6.

    Google Scholar 

  6. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. Infliximab-GCA study group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146(9):621–30.

    Article  PubMed  Google Scholar 

  7. Pfadenhauer K, Roesler A, Golling A. The involvement of the peripheral nervous system in biopsy proven active giant cell arteritis. J Neurol. 2007;254(6):751–5.

    Article  CAS  PubMed  Google Scholar 

  8. Vishwanath S, Relan M, Shen L, Ambrus JL Jr. Update on the use of biologics in vasculitides. Curr Pharm Biotechnol. 2014;15(6):558–62.

    Article  CAS  PubMed  Google Scholar 

  9. Seko Y, Takahashi N, Tada Y, Yaqida H, Okumura K, Naqai R. Restricted usage of T-cell receptor Vγ-Vδ genes and expression of co-stimulatory molecules in Takayasu's arteritis. Int J Cardiol. 2000;75:S77–83.

    Article  PubMed  Google Scholar 

  10. Forbess L, Bannykh S. Polyarteritis nodosa. Rheum Dis Clin N Am. 2015;41(1):33–46.

    Article  Google Scholar 

  11. Chalk C, Dyck J, Conn D. Vasculitic neuropathy. In: Thomas PK, Dyck PJ, editors. Peripheral neuropathy. Philadelphia: Saunders; 1993. p. 1424–143.

    Google Scholar 

  12. Midroni G, Bilbao J. Vasculitic neuropathy. In: Midroni G, Bilbao J, editors. Biopsy diagnosis of peripheral neuropathy, vol. 1995. Boston: Butterworth-Heinemann; 1995. p. 241–62.

    Chapter  Google Scholar 

  13. Younger DS. Vasculitis of the nervous system. Curr Opin Neurol. 2004;17(3):317–36.

    Article  PubMed  Google Scholar 

  14. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–100.

    Article  CAS  PubMed  Google Scholar 

  15. Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, et al. Churg- Strauss syndrome. Autoimmun Rev. 2015;14(4):341–8.

    Article  CAS  PubMed  Google Scholar 

  16. Wolf J, Bergner R, Mutallib S, Buggle F, Grau AJ. Neurologic complications of Churg-Strauss syndrome--a prospective monocentric study. Eur J Neurol. 2010;17(4):582–8.

    Article  CAS  PubMed  Google Scholar 

  17. McKinney EF, Willcocks LC, Broecker V, Smith KGC. The immunopatology of ANCA- associated vasculitis. Semin Immunopathol. 2014;36(4):461–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33(8):1101–7.

    Article  CAS  PubMed  Google Scholar 

  19. Nishino H, Rubino FA, Parisi JE. The spectrum of neurologic involvement in Wegener’s granulomatosis. Neurology. 1993;43(7):1334.

    Article  CAS  PubMed  Google Scholar 

  20. de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, et al. Infliximab or rituximab for refractory Wegener’s granulomatosis: long-term follow-up. A prospective randomised multicentre study on 17 patients. Clin Exp Rheumatol. 2011;29(1Suppl 64):S63–71.

    PubMed  Google Scholar 

  21. Morgan MD, Drayson MT, Savage CO, Harper L. Addition of infliximab to standard therapy for ANCA-associated vasculitis. Nephron Clin Pract. 2011;117(2):c89–97.

    Article  CAS  PubMed  Google Scholar 

  22. International Team for the Revision of the International Criteria for Behcet’s Disease. Revision of the International criteria for Behcet’s disease (ICBD). Clin Exp Rheumatol. 2006;42:S14–5.

    Google Scholar 

  23. Dinc A, Erdem H, Simsek I, Pay S. Immunopathogenesis of Behcet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417–24.

    Article  PubMed  Google Scholar 

  24. Kidd D. Neurological complications of Behçet’s syndrome. Curr Neurol Neurosci Rep. 2012;12(6):675–9.

    Article  CAS  PubMed  Google Scholar 

  25. Kikuchi H, Aramaki K, Hirohata S. Low dose MTX for progressive neuro-Behçet’s disease. A follow-up study for 4 years. Adv Exp Med Biol. 2003;528:575–8.

    Article  CAS  PubMed  Google Scholar 

  26. Saip S, Akman-Demir G, Siva A. Neuro-Behçet syndrome. Handb Clin Neurol. 2014;121:1703–23.

    Article  PubMed  Google Scholar 

  27. Kararizou E, Davaki P, Karandreas N, Davou R, Vassilopoulos D. Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J Rheumatol. 2005;32(5):853–8.

    PubMed  Google Scholar 

  28. Hammad TA, Hajj-Ali RA. Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome. Curr Atheroscler Rep. 2013;15(8):346.

    Article  PubMed  Google Scholar 

  29. Alba MA, Espígol-Frigolé G, Prieto-González S, Tavera-Bahillo I, Martínez AG, Butjosa M, et al. Central nervous system vasculitis: still more questions than answers. Curr Neuropharmacol. 2011;9:437–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Salvarani C, Brown RD Jr, Christianson TJ, et al. Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients. Arthritis Rheumatol. 2015;67:1637–45.

    Article  CAS  PubMed  Google Scholar 

  31. De Boysson H, Zuber M, Naggara O, et al. French Vasculitis Study Group and the French NeuroVascular Society. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol. 2014;66:1315–26.

    Article  PubMed  Google Scholar 

  32. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51(suppl 5):v3–v11.

    Article  CAS  PubMed  Google Scholar 

  33. Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve. 2001;24(2):154–69.

    Article  CAS  PubMed  Google Scholar 

  34. Caballol Pons N, Montalà N, Valverde J, Brell M, Ferrer I, Martínez-Yélamos S. Isolated cerebral vasculitis associated with rheumatoid arthritis. Joint Bone Spine. 2010;77(4):361–3.

    Article  PubMed  Google Scholar 

  35. da Côrte FC, Neves N. Cervical spine instability in rheumatoid arthritis. Eur J Orthop Surg Traumatol. 2014;24(Suppl 1):S83–91.

    PubMed  Google Scholar 

  36. Matsumoto T, Nakamura I, Miura A, Momoyama G, Ito K. New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review. Clin Rheumatol. 2013;32(2):271–5.

    Article  PubMed  Google Scholar 

  37. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

    Article  CAS  PubMed  Google Scholar 

  38. Greenberg BM. The neurologic manifestations of systemic lupus erythematosus. Neurologist. 2009;15(3):115–21.

    Article  PubMed  Google Scholar 

  39. Streifler JY, Molad Y. Connective tissue disorders: systemic lupus erythematosus, Sjögren’s syndrome, and scleroderma. Handb Clin Neurol. 2014;119:463–73.

    Article  PubMed  Google Scholar 

  40. Wigren M, Nilsson J, Kaplan MJ. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention. J Intern Med. 2015;278:494–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579–96.

    Article  CAS  PubMed  Google Scholar 

  42. Zuber JP, Spertini F. Immunological basis of systemic sclerosis. Rheumatology. 2006;45(suppl 3):iii23–5.

    CAS  PubMed  Google Scholar 

  43. Allanore Y, Kahan A. Primary myocardial involvement in systemic sclerosis. Rheumatology. 2006;45:iv14–7.

    PubMed  Google Scholar 

  44. Amaral TN, Peres FA, Lapa AT, Marques-Neto JF, Appenzeller S. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum. 2013;43(3):335–47.

    Article  PubMed  Google Scholar 

  45. Agarwal P. Immunopathogenesis of Sjögren’s syndrome. J Indian Rheumatol Assoc. 2003;11:71–5.

    Google Scholar 

  46. Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, et al. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol. 2011;30(4):485–90.

    Article  PubMed  Google Scholar 

  47. Park K, Haberberger RV, Gordon TP, Jackson MW. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren’s syndrome. Arthritis Rheum. 2011;63(5):1426–34.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Athens Medical School, Aeginition Hospital, Athens, Greece

    Anastasia Bougea MD, PhD & Nikolaos Spantideas PhD

Authors
  1. Anastasia Bougea MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaos Spantideas PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anastasia Bougea MD, PhD .

Editor information

Editors and Affiliations

  1. Hammersmith Campus, Imperial College London National Heart and Lung Institute, London, United Kingdom

    Susanne Sattler

  2. Hammersmith Campus, Imperial College London National Heart and Lung Institute, London, United Kingdom

    Teresa Kennedy-Lydon

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Bougea, A., Spantideas, N. (2017). Vasculitis in the Central Nervous System. In: Sattler, S., Kennedy-Lydon, T. (eds) The Immunology of Cardiovascular Homeostasis and Pathology. Advances in Experimental Medicine and Biology, vol 1003. Springer, Cham. https://doi.org/10.1007/978-3-319-57613-8_9

Download citation

Publish with us

Policies and ethics

Search

Navigation